DFT study of the selectivity of DOPA-decarboxylase

被引：0
|
作者：
Ritter, Abby [1 ]
Harrison, Emily [2 ]
Peterson, Larryn [2 ]
Cafiero, Mauricio [3 ]
机构：
[1] Rhodes Coll, Chem, Cape Girardeau, MO USA
[2] Rhodes Coll, Dept Chem, Memphis, TN 38112 USA
[3] Rhodes Coll, Memphis, TN 38112 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 251卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
288
引用
收藏
页数：1
相关论文
共 50 条
  • [31] MODULATION OF DOPA-DECARBOXYLASE MESSENGER-RNA IN EPIDERMIS TISSUE OF BLOWFLY LARVAE BY ECDYSONE
    SEKERIS, CE
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1976, 357 (04): : 494 - 495
  • [32] CORRELATION OF RENAL DOPA-DECARBOXYLASE (DDC) ACTIVITY WITH PLASMA PROLACTIN AND DOPAMINE LEVELS IN PREGNANCY
    HAMAUE, N
    MINAMI, M
    TOGASHI, H
    SAITO, H
    PARVEZ, SH
    BIOGENIC AMINES, 1989, 6 (06) : 565 - 570
  • [33] EFFECT OF PERIPHERAL DOPA-DECARBOXYLASE INHIBITOR ON L-DOPA INHIBITION OF HUMAN HYPOTHALAMUS-HYPOPHYSIS-CORTICOADRENAL SYSTEM
    BALESTRERI, R
    BERTOLINI, S
    ELICIO, N
    COSTA, S
    BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1974, 50 (12): : 831 - 837
  • [34] Is There a Difference between Levodopa/Dopa-Decarboxylase Inhibitor and Entacapone and Levodopa/Dopa-Decarboxylase Inhibitor Dose Fractionation Strategies in Parkinson's Disease Patients Experiencing Symptom Re-Emergence due to Wearing-Off?
    Destee, Alain
    Rerat, Karin
    Bourdeix, Isabelle
    EUROPEAN NEUROLOGY, 2009, 61 (02) : 69 - 75
  • [35] AMINE LEVELS, MONOAMINE OXIDASE AND DOPA-DECARBOXYLASE ACTIVITIES IN THE GASTRO-INTESTINAL TRACT OF THE RAT
    KLINGMAN, GI
    KARDAMAN, S
    HABER, J
    LIFE SCIENCES, 1964, 3 (11) : 1355 - 1360
  • [36] DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease
    Appleton, Ellen
    Khosousi, Shervin
    Ta, Michael
    Nalls, Michael
    Singleton, Andrew B.
    Sturchio, Andrea
    Markaki, Ioanna
    Paslawski, Wojciech
    Iwaki, Hirotaka
    Svenningsson, Per
    TRANSLATIONAL NEURODEGENERATION, 2024, 13 (01):
  • [37] DOPAMINE EXCESS IN A SYMPATHECTOMY-INDUCED ORTHOSTATIC HYPOTENSION - NEW TREATMENT WITH AN INHIBITION OF DOPA-DECARBOXYLASE
    LEBEL, M
    KUCHEL, O
    BARBEAU, A
    HAMET, P
    CUCHE, JL
    NOWACZYNSKI, W
    BOUCHER, R
    GENEST, J
    UNION MEDICALE DU CANADA, 1973, 102 (04): : 819 - 825
  • [38] IMMUNOHISTOCHEMICAL STUDIES ON PHENYLETHANOLAMINE-N-METHYLTRANSFERASE, DOPA-DECARBOXYLASE AND DOPAMINE-BETA-HYDROXYLASE
    GOLDSTEIN, M
    FUXE, K
    HOKFELT, T
    JOH, TH
    EXPERIENTIA, 1971, 27 (08): : 951 - +
  • [39] EFFECT OF A TREATMENT WITH L-DOPA OR L-DOPA AND DOPA-DECARBOXYLASE INHIBITORS ON BRAIN CONCENTRATION OF S-ADENOSYL-L-METHIONINE IN MICE
    STRAMENTINOLI, G
    CATTO, E
    AGNOLI, A
    PHARMACOLOGY, 1981, 22 (01) : 85 - 86
  • [40] Analysis of efficacy in patients with symptomatic neurogenic orthostatic hypotension treated with droxidopa and dopa-decarboxylase inhibitors
    Biaggioni, I.
    Low, P.
    Rowse, G.
    Kaufmann, H.
    MOVEMENT DISORDERS, 2012, 27 : S422 - S423
12345